Institutional Fund
Artia Global Partners LP
Miami, FLCIK 19379646 filings on record
Portfolio Value
$443.52M
Q1 2026
Holdings
48
Reported positions
New Buys
10
Opened this quarter
QoQ Change
-28.7%
from $622.42M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Insmed Inc23.2%
- Abivax SA15.1%
- Eli Lilly & Co7.9%
- Trevi Therapeutics Inc5.4%
- Argenx Se4.9%
- Astrazeneca PLC4.2%
- Other39.3%
Portfolio Holdings
48 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Insmed Inc | 628.7K | $102.81M | 23.2% | −53.5K | Reduced |
| 2 | Abivax SA | 600.7K | $66.89M | 15.1% | 0 | Held |
| 3 | Eli Lilly & Co | 38.2K | $35.15M | 7.9% | −12.3K | Reduced |
| 4 | Trevi Therapeutics Inc | 2.01M | $24.02M | 5.4% | 0 | Held |
| 5 | Argenx Se | 29.7K | $21.72M | 4.9% | −35.0K | Reduced |
| 6 | Astrazeneca PLC | 95.4K | $18.81M | 4.2% | +95.4K | New |
| 7 | Newamsterdam Pharma Company | 503.9K | $16.13M | 3.6% | 0 | Held |
| 8 | Dianthus Therapeutics Inc | 163.0K | $13.68M | 3.1% | −42.1K | Reduced |
| 9 | Revolution Medicines Inc | 125.0K | $12.16M | 2.7% | +20.8K | Added |
| 10 | Ionis Pharmaceuticals Inc | 144.4K | $10.84M | 2.4% | 0 | Held |
38 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio